Reductions in the cost of whole-genome sequencing (WGS) and whole-exome sequencing (WES) are opening the door to affordable sequencing of patients and the development of precision medicine 1 . Historically, genomic studies have focused on single-nucleotide polymorphisms (SNPs) because of their high prevalence and the relative simplicity of detecting them 2 . However, recent advancements in sequencing technologies and computational methods have broadened the focus to include the role of insertion and deletion (indel) mutations. Indel mutations are defined by the addition or loss of one or more nucleotides of a DNA sequence. Frameshift mutations are a highly disruptive class of indel mutations that alter the reading frame of protein coding sequences 3 and have been strongly implicated in neurodevelopmental disorders, cardiovascular diseases, cancer and many other human diseases [4] [5] [6] [7] . In evolutionary analysis, the role of indels has been established and emphasized in both eukaryotic and prokaryotic genomes 8, 9 . In particular, studies have shown widespread occurrences of loss-of-function variants, especially indels, in protein-coding genes of humans, plants and other species [10] [11] [12] .
read is split into two segments spanning structural variation (SV) breakpoints, methods such as Pindel 22 and Splitread 23 are able to detect indels, especially deletions. Theoretically, this approach should be effective for deletions of any size, but the sensitivity is reduced because of the short read length of current sequencing technologies. Cortex, one of the first approaches for variant detection using whole-genome de novo assembly with de Bruijn graphs, was reported to overcome such issues caused by short reads and alignment artifacts 24 . However, in practice this method is less sensitive than expected, and accurate indel detection instead requires a fine-grained and localized analysis. Thus, in recent years, there has been much interest in developing specialized local assembly and microassembly methods 17 .
One of the most sensitive and accurate approaches for indel detection from short read data is a microassembly algorithm, Scalpel. It was previously demonstrated to have substantially improved accuracy over eight algorithms, including GATKHaplotypeCaller 25 (v3.0) and SOAP-indel 26 (v2.01), whereas other methods report a large number of false-negative calls 16 . In fact, Scalpel achieves very high accuracy (positive predictive value = 90%) of indel detection even on 30× WGS data ( Fig. 1) . In this protocol, we describe the use of Scalpel for indel detection from whole-genome and whole-exome capture sequencing experiments. We introduce three different modes of indel detection-de novo, somatic and single-sample-for different study designs. First, the de novo mode is useful for calling germline de novo variants in nuclear families up to four people. Second, the somatic mode is useful for identifying somatic changes within matched samples, especially tumor/normal pairs in cancer studies. Finally, the single-sample mode is useful for studies of a single proband.
Overview of Scalpel microassembly strategy
Scalpel is a computational tool specifically designed to detect indels in next-generation sequencing (NGS) data. Figure 2 outlines the main steps for the analysis of a sequencing data set using Scalpel. To highlight the main focus of this protocol, the left panel of Figure 2 depicts the specific scenario of detecting de novo indels in a quartet family composed of two parents and two children.
Box 1 | Representing and annotating indels
Unlike SNPs, which are always represented with a unique genomic coordinate and base substitution, an indel can have an ambiguous representation. For example, if there is a 1-bp deletion in a long homopolymer (…AAAAAA…), deleting any A will give rise to the same haplotype, but it will have a different position. A more complex example, which gives rise to two logically equivalent 3-bp deletions, is shown in the following figure: Note that two different 3-bp sequences can be deleted (GGA or AGG) at two different locations, generating the same alternative sequence. The solution to this ambiguity is to consistently left-or right-normalize the signature of the mutations. This operation consists of shifting the start position of the mutation to the left (or right) as long as the resulting sequence (after the deletion or insertion of the specific number of bases) is still the same as the one generated by the original mutation. Note that at the end of this process the new signature for the indel can have a new coordinate, as well as a new (deleted or inserted) sequence, but the size must remain the same as that of the original. For example, in the case of the previous 3-bp indel, the deletion is shifted to the left by two positions and a new 3-bp sequence (GGA) is deleted.
As different methods might report different signatures for the same indel, it is essential to consistently normalize the signature (typically left-normalization) when comparing indels called by different tools or when querying different databases (dbSNP, 1000G, OMIM and so on). Scalpel always returns a list of variants that are left-normalized. However, if it is unclear what representation has been used for a set of variants made by other callers, there are different tools available that can normalize a list of input variants, including 'vt normalize' 48 , 'bcftools norm' 21 and 'GATK LeftAlignIndels' 49 . Indel normalization is now becoming standard practice and widely used variant annotation software, such as Annovar 45 , is now enforcing left-normalization as the default representation for indels. Updated variants databases (e.g., 1000 Genome Project, dbSNP and ExAC) were made available, and Annovar users are highly encouraged to left-normalize (using any of the previously listed tools) the variants before annotation. However, note that some of the databases use right-normalization or normalize relative to the sense of the transcript, so users are encouraged to refer to the documentation for each tool separately.
Annotation of variants is a common and crucial step that is necessary to identify potentially disease-relevant DNA mutations. Among the many different tools available for this task, three of the most widely used annotators are Annovar 45 , SnpEff 50 and Variant Effect Predictor 51 . It has been shown that the choice of both the annotation software and transcript set can have a large impact on the classification of variants 52 , suggesting the use of multiple annotation software when analyzing variants. The choice of the annotation program to use is also based on the ability to support different sets of transcripts, different cancer variants, multiple variant databases, integration with other tools and so on. Different annotators often produce different results, although here we opted to use Annovar because it is easy to use, the software is well documented, it is continuously updated with the most recent databases and, as previously discussed, it supports left-normalization as the default indel representation. We highly recommend reviewing the original Scalpel publication for a more extensive description of the method 16 . Here we describe the main ideas of the microassembly strategy used by Scalpel, as well as the strategies and filters that can be applied for optimizing the accuracy with different experimental designs or sequencing conditions, and describe the new developments since the original publication of the software (v0.1.1 beta).
Before running Scalpel, the sequencing reads (whole genome, whole exome or custom capture) must be aligned to a reference genome using a short-read-mapping algorithm such as BWA-MEM (http://bio-bwa.sourceforge.net/), similar to the steps used for SNP calling or other analyses. It is worth noting that computationally expensive procedures such as indel realignment and base quality recalibration are not necessary with Scalpel. Unlike in those analyses, the alignments are not directly used to find indels but instead are used to localize the analysis into computationally tractable regions. After alignment, Scalpel examines all the genomic regions provided in the input by the user in Browser Extensible Data (BED) format (right panel, Fig. 2 ). For each region, reads that align in the region or whose mates align in the region are extracted from the alignment and assembled independently of the reference using a de Bruijn assembly paradigm. If the size of a region is larger than the user-defined windowsize parameter, a sliding-window approach will be applied to this target region based on the window-size and step-size parameters. In order to reduce the number of errors in locally highly repetitive regions, Scalpel automatically performs a local repeat analysis coupled with a self-tuning k-mer strategy that iteratively increases the k-mer size until a 'repeat-free' local assembly graph is built. In this context, a repeat-free graph is a graph without exact repeats, which would introduce cycles into the de Bruijn graph, as well as near-identical repeats (up to three mismatches by default). The advantage of this strategy is that each genomic window will be analyzed using an optimal k-mer specifically tuned according to its sequence composition. The graph is then exhaustively explored to identify end-to-end paths spanning the selected region. These paths, representing de novo-assembled sequences of the short reads, are then aligned to the reference window to detect candidate mutations using a sensitive gapped sequence aligner based on the Smith-Waterman algorithm.
Scalpel supports three modes of operation: single, de novo and somatic. In the single mode, Scalpel detects indels in one single data set (e.g., one individual exome or genome). In the de novo mode, Scalpel detects de novo indels in a quad family (father, mother, affected child and unaffected sibling). In the somatic mode, Scalpel detects somatic indels from the sequencing data coming from matched tumor and normal samples. In this protocol, we illustrate the use of Scalpel by focusing on the de novo mode; however, we describe the alternative operation modes in Box 2, including a discussion of the computational requirements for running Scalpel and how those differ between whole-genome and whole-exome studies. Box 3 provides guidelines on how to export and filter the mutations based on coverage and quality scores and how those operations could affect sensitivity and specificity. Finally, Box 4 presents additional advanced operations for when using Scalpel for deep-sequencing projects or detection of longer indels (>100 bp).
In the first version of Scalpel (v0.1.1), all possible paths in the final graph were exhaustively examined using a breadth-firstsearch traversal approach. This strategy worked well for the majority of the human genome, with limited numbers of mutations, leading to the generation of one or two paths. However, this step is computationally expensive for a small number of regions with high levels of heterozygosity or higher sequencing Scalpel was run in single mode on 30× Illumina Hiseq 2000 2 × 100 bp WGS data described in Narzisi et al. 16 and later analyzed in Fang et al. 18 . This figure shows the size distribution of valid (green) and invalid (gray) indels that were randomly selected for validation (using targeted resequencing) from the two previous studies. This validation set includes 160 and 145 candidate variants that were WGS-WES intersected and WGS-specific, respectively. Among a total of 305 candidates, 90% of them (274) 34 . Although they all use a local read assembly step, these tools differ in how they explore the graphs and in their relative ability to handle repeat structures. Scalpel is unique because of on-the-fly repeat analysis that it uses to automatically optimize the parameters used for different regions of the genome, and the extensive set of filters that can be applied to correct for different sequencing conditions, among several other enhancements. In combination, these features enable Scalpel to accurately identify indel variants in diverse sequencing conditions and sequence contexts. Small-scale repeats are especially challenging for most other indel-finding algorithms, although they are carefully detected and
Box 2 | Alternative operation modes and computational requirements
Scalpel is designed for UNIX-type operating systems, and it provides a command-line interface. Users are expected to have a basic familiarity with operating in a UNIX environment. The discovery pipeline of Scalpel is executed from the command line via a master (perl) script called 'scalpel-discovery', and it requires a minimum number of parameters describing the input alignment files (BAM format), the reference genome (FastA format) and the target region (BED format) to analyze.
Scalpel supports three operation modes: single, somatic and de novo. The de novo mode is described and used in the procedure of this protocol. Here we report the basic usage and command-line parameters for the other two operation modes. To call variants on one single sample (e.g., a single-exome or single whole-genome data set), use the following command:
$ scalpel-discovery --single --bam file.bam --bed regions.bed --ref genome.fa where 'file.bam' is the bwa aligned BAM file of the reads (after sorting, indexing and PCR duplicates marking), 'regions.bed' contains the set of target regions in BED format (typically the list of exonic coding regions) and 'genome.fa' is the reference sequence in FastA format. It is important to provide to Scalpel the same reference file that was used to align the reads in the BAM file.
If calling variants on a tumor/matched normal pair, execute Scalpel as follows:
where 'regions.bed' and 'genome.fa' are the same files as described before; 'normal.bam' and 'tumor.bam' are the BWA-aligned BAM files of the reads for the normal tissue and the tumor tissue sample, respectively. Also note the use of the '--two-pass' option, which enables Scalpel to perform a second round of indel verification on the candidate list of somatic mutations to reduce the number of false-positive calls. For example, in the case of a tumor/normal pair, a more sensitive analysis is performed on the normal sample to identify any signature of the candidate mutation in the tumor that was missed during the first pass of the analysis. We highly recommend using the '--two-pass' option for de novo and somatic studies. Exceptions to this rule are studies with extremely high coverage (e.g., 1,000× or more) that can be obtained, for example, in panel studies of cancer samples, for which the use of the two-pass option is not required. It is best to run Scalpel on a multicore computer with at least 64 GB of RAM. The relative computational requirements depend on the type of data being analyzed. For example, in the case of whole-exome analysis, ten CPUs and a minimum of 10 GB of RAM will be enough to perform the analysis in a few hours. In the case of a whole-genome study, in order to reduce the memory requirements, it is recommended that Scalpel be run on each chromosome separately and then that the lists of detected call sets be merged. Given the more uniform coverage distribution of whole-genome data and the increasing read length of Illumina technology, we also recommend increasing the window size (default 400 bp) to 600 bp or larger. For example, the following command can be used to call variants on chromosome 22 using ten CPUs:
$ scalpel-discovery --single --bam file.bam --ref genome.fa --bed 22:1-51304566 --window 600 --numprocs 10
Box 3 | Exporting variants and filtering considerations
By default, Scalpel exports the list of detected indels in a VCF file within the selected output directory according to the default parameters. However, it is recommended that different filtering criteria be explored using the export tool ('scalpel-export'). The raw list of mutations detected by Scalpel is always available in a database within the output directory, which can be queried with the export tool using the following command:
All detected mutations are exported, but following the standard practices of the VCF format, high-quality mutations are flagged as 'PASS' in the 'FILTER' column. For non-PASS mutations, the 'FILTER' field contains the list of filters that were applied to the variant, explaining why the variant was considered to be of low quality. For example, in the VCF snippet below, the first indel is of high quality and is labeled as 'PASS', whereas the second indel does not satisfy the minimum Phred-scaled Fisher's exact test score requirement and it is flagged as 'LowFisherScore': These filters can be further controlled using some of the command-line parameters available in the 'scalpel-export' tool. Like the scalpel-discovery command, the export tool requires the mode of operation to be specified according to type of study (single, somatic and de novo). Different parameters and filters are available for each operation mode; these are summarized in the following table:
Here we discuss some of the most important ones and give recommendations on how to adjust them according to the type of study.
VAF and support.
A high number of supporting reads and high VAF are typical signals of strong evidence for a variant. All three modes of operation provide parameters to control the thresholds used for the minimum number of supporting k-mers ('--min-alt-count', '--min-alt-count-tumor', '--max-alt-count-normal') and minimum allele fraction for the alternative allele ('--min-vaf', '--min-vaf-tumor', '--min-vaf-affected'); these are used to filter low-quality variants. Although default values are provided, optimal cutoffs for these numbers depend on the coverage available for the sample and the type of study (single, somatic and de novo). For example, as somatic calls are typically found at lower VAFs in the data, the user may need to adjust these parameters according to the level of purity, ploidy and clonality (if available) of the data.
Contamination in normal samples. The normal sample matched to the tumor is typically assumed not to be contaminated with the tumor sample. However, in practice, it is possible to have a very low level of contamination of the tumor in the normal sample as well. In this scenario, two parameters, '--min-alt-count-tumor' and '--min-vaf-tumor' (which by default assume no contamination in the normal sample), can be used to allow mutations in the tumor that are also found in the normal sample at low allele fraction to be called as somatic.
Statistical test and scoring. For germline (inherited and de novo) mutations, the relative balance between the alternative and reference counts is estimated using the χ 2 -test statistic. The cutoff used can be adjusted via the 'max-chi2-score' parameter. A larger value will increase sensitivity but produce a larger number of false positives. We recommend using χ 2 score 20 to export high-confidence indels. Differently from germline mutations, which are expected to be relatively balanced in their reference and alternative counts, somatic variants are usually out of balance due to several known characteristics of cancer data (e.g., ploidy, clonality and purity). The Fisher's exact test is generally used to determine whether there are nonrandom associations between the allele balances in the tumor and those in the normal samples. Scalpel internally scores the mutations by computing a Phred-scaled P value Fisher's exact test score, and the filtering cutoff can be adjusted via the '--min-phred-fisher' parameter. By default, this parameter is set to 10, but lower values will increase sensitivity at the cost of specificity. properly analyzed by Scalpel. We encourage the users to read the review on the challenge of small-scale repeats for indel discovery for a more in-depth discussion of the differences 17 . Most indel-finding tools, including Scalpel, have been designed to be general variant callers for detecting mutations across every region of the reference genome. However, some classes of indel, specifically the ones located within STRs, are known to be inherently more difficult to detect because of the high level of replication slippage events (e.g., homopolymers) associated with Illumina technology. Very few tools have been designed to specifically deal with the complexity of calling within STR regions. Users who specifically require the ability to call variants within STRs are
Box 4 | Advanced Scalpel operations
Variant calling is a computational step that is widely applied to a multitude of different projects and data sets, and, as expected, the default parameters of the tool cannot handle all situations equally well. Here we describe how to adjust the optional parameters in a few common scenarios.
Deep sequencing. Some projects require deep sequencing to allow in cancer, for example, the detection of low-allele-fraction mutations. With higher coverage, there is also enrichment of the errors in the data. In the most extreme scenarios of very deep sequencing experiments with 1,000-fold coverage or greater (e.g., cancer gene panels), these errors contribute to an increased complexity of the assembly graph to the point at which the associated region to assemble would be discarded. Thus, it becomes necessary to increase the minimum k-mer coverage used to remove low-coverage nodes (parameters '--lowcov' and '--covratio'). This can typically solve the problem by reducing the complexity to a level at which the graph can be efficiently analyzed. In addition, by default, regions that have >10,000-fold coverage are not processed. If higher coverage is expected, the maximum average coverage allowed per region must be adjusted accordingly ('--maxregcov' parameter).
>Detecting very long (>100 bp) indels. There are cases in which researchers might have some evidence or prior knowledge about the presence of larger (>100 bp and up to 1 kb) indels in their data set. In this scenario, Scalpel can be used to genotype these loci for the presence of the mutations. Two parameters can be adjusted to handle and improve the sensitivity in such cases:
• '--coords': using this parameter the user can specify a list of selected coordinates to examine. The expected format is a tab-delimited list of chromosome names and positions.
• '--window': by default, the list of positions is analyzed using a window size of 400 bp. For indels approaching the window size or larger, it is necessary to increase this parameter to allow for enough unique sequence on both sides of the mutation. For example, in the case of a 400-bp insertion, we recommend using a window size of at least 600 bp so that 100 bp of unique sequence can be used to anchor the mutation to the reference on both sides.
Inspecting the assembly. In some special cases, the user may be interested in examining the final assembly generated by Scalpel. This information is stored internally by the program in the log files. By default, the log files are not saved in the output directory, as they can be extremely large in size, especially for whole-genome analysis. It is possible, however, to change this behavior by using the '--logs' option, but we recommend doing so only if a relatively short list of small regions is being analyzed. The file contains detailed information describing the different stages of the assembly. It is out of the scope of this article to describe the complete format of the log files; instead, we will focus on the section containing the final assembly and alignment of the region of interest. A typical alignment of the assembled sequence to the reference will look like the following one: where r′ is the reference sequence, p′ is the sequence assembled by Scalpel, followed by information about the minimum and maximum coverage across the assembly, and d′ is the alignment string showing the differences between the reference and the assembled sequence. In this case, the assembly contains a complex mutation composed of an insertion of four bases (TATT) together with single-base substitution (G>T). The last line reports the genomic coordinates of the region, followed by (i) the number of cycles detected (cycle: 0), (ii) the total number of matches to the reference (match: 65), (iii) the number of SNPs, insertions and deletions (snp: 1 ins: 4 del: 0) and (iv) a list of signatures describing each mutation. The signature starts with the position of the mutation, followed by ':' and a list of fields separated by the symbol '|' (e.g., 65100058:----|TATT|6.0|5|G|G).
In order, each field contains the following:
• Position strongly advised to use the following two tools: RepeatSeq 35 and lobSTR 36 . More recently, more complex classes of indels have been also discovered and analyzed in which a simultaneous deletion and insertion of DNA fragments of different sizes can co-occur at the same genomic location. A new tool, Pindel-C, has been specifically designed to handle these complex indels 37 , and we encourage the user to use such tools for detecting complex indels in cancer-associated genes.
Limitations of the protocol and software Scalpel provides several advantages over standard mapping approaches but, similar to any bioinformatics algorithm, it does not attempt to address all possible types or sizes of mutations at once. In our experiments, Scalpel was able to reliably detect deletions of up to 400 bp (including deletions of Alu mobile elements) and insertions shorter than 200 bp, but its sensitivity is reduced for longer indels, given the available read lengths (data not shown).
Even within this size range, Scalpel-and all pipelines-has lower sensitivity for indels in low-coverage regions that are supported by very few reads. In the worst-case scenario, a combination of low coverage within a complex repeat region may require a k-mer size that is too large for assembling across the mutation, leading to false negatives. Phasing of the discovered mutations is not supported and, given the locality of the assembly, it would be possible to phase only mutations within the same window (400 bp, by default). Thanks to the new advances in long-molecule sequencing technologies (e.g., PacBio, 10× Genomics), in the near future it will be possible to combine such technologies for phasing mutations that are hundreds of kilobases to megabases apart. For variant-calling purposes, it is ideal to have a high-quality reference genome available. This is also true for indel calling with Scalpel because assembly errors might incorrectly increase the number of variants, and the read localization will not be effective unless a complete representation of the genome is available. Users working with data from a genome without a reference should first generate a high-quality assembly using one of the several wholegenome assemblers 38, 39 . This procedure can be easily adapted to work with a draft assembly, but no testing has been performed and the results could be unpredictable. Tumor/normal samples and samples from multiple family members can be analyzed together, but joint calling across a large number of samples is not supported by Scalpel, although population frequencies can be used to identify systematic sequencing errors. This protocol also assumes that sequencing was performed using the Illumina sequencing platform, including MiSeq, HiSeq 2000 and HiSeq X sequencers. Other sequencing technologies (e.g, Ion Torrent, Sanger and SOLiD) can also be used for studies such as the one reported here, but the software pipeline used in this protocol does not support them. Finally, no graphical user interface is available for the steps performed in this protocol; all the operations are performed through the UNIX shell. Some of the tools used here, such as BWA and Picard Tools, are now available through cloud-based web interface systems such as Galaxy (https://usegalaxy.org/). We look forward to seeing Scalpel integrated into such systems in the near future.
Overview of the protocol
In the PROCEDURE, we present a step-by-step protocol for identifying de novo variants in a HapMap family from PCR-free Illumina HiSeq2000 data. Here, we provide an overview of using Scalpel to discover de novo and inherited indel mutations within a quad family of two parents and two children, one affected and one unaffected with a certain phenotype. It should be noted that internally within the algorithm, the two children are treated identically, which can support additional use cases. The input to the algorithm can be data from WGS, WES or targeted sequencing experiments. A two-pass search mode is used by Scalpel when calling de novo or somatic mutations. In the first pass, Scalpel identifies indels in each of the samples using parameters designed to balance between sensitivity and specificity. In the second pass, Scalpel performs a more sensitive search in the parents for the indels identified in the children to reduce false-positive de novo calls in regions of low coverage in the parents. We also show how to extract indel calls that fall into target regions and filter out false-positive calls with respect to their sequence composition and variant quality (Fig. 3) . Finally, we present one of the available methods for annotating the mutations, to prioritize particularly any potential disease-related mutations. Although we use Scalpel for generating the indel calls, the protocol provides general guidelines for standard operations required to analyze and evaluate indel calls. We also illustrate several sources of indel calling errors, which could be introduced by library construction, sequencing or alignment. Whenever possible, visualization of data/results is performed using Integrative Genomics Viewer (IGV) alignments, and auxiliary scripts are provided for plotting size, allele fraction distribution and so on. This protocol is based on the use of v0.5.3 of the Scalpel software. Users should keep in mind that the software is continuously under development, and some of the parameters, file names and output formats could change in the new releases of the software. The most recent version of the code and documentation is always available at http://scalpel.sourceforge.net. This protocol follows very closely a typical usage of the software; however, we recommend that the users perform the full procedure described herein before running the pipeline on their own data.
Experimental design
In this protocol, we use publicly available WGS data to detect and analyze indels within a family. However, when designing a new study, researchers are typically faced with the problem of choosing suitable sequencing and bioinformatics strategies to answer the relevant scientific questions. There are many factors that have a role in study design, including depth of coverage, read length, parameter tuning, WGS versus WES protocols, the use of PCR amplification and cost per base pair. In this section, our goal is to provide some guidelines on the impact of such different experimental design choices on the sensitivity and accuracy of indel detection.
WGS versus WES.
Although WES is a cost-effective approach to identifying genetic mutations within the coding region, it suffers from several major limitations due to a combination of coverage biases, low capture efficiency and errors introduced by PCR amplification. For example, an indel located near the end of a target region may not be well covered by sequencing reads, which limits detection ability. In addition, exome capture kits are typically designed to pull down a region of ~400 bp around an exon, which can limit detection of large indels within coding regions or near splice sites. On the other hand, albeit with higher cost, WGS comes with several benefits, including more uniform coverage, freedom from capture efficiency biases and the inclusion of the noncoding genome. In the context of detecting indels, it has been shown that the accuracy of indel detection with WGS data is much greater than that with WES data, even within the targeted regions 18 . Table 1 shows that the validation rate of WGSspecific indels is much higher as compared with that of WESspecific indels (84% versus 57%). Specifically, WGS has a unique advantage over WES in identifying many more indels that are longer than 5 bp; these were successfully confirmed by experimental validation (25 versus 1). When using WGS, it was estimated that 60× depth of coverage from the HiSeq platform would be needed to recover 95% of the indels detected by Scalpel. In particular, detection of heterozygous indels naturally requires deeper sequencing coverage relative to detection of homozygous indels (Fig. 4) . WGS at 30× using the HiSeq platform is not sufficient for sensitive indel discovery, resulting in at least 25% false-negative rates for heterozygous indels. However, these requirements can rapidly change with the longer reads and lower error rates provided by newer instruments.
PCR-free protocols. PCR is a widely used and useful technique for amplifying DNA fragments of interest and for attaching various linkers or barcodes for sequencing. However, small amounts of contaminating material can also be amplified without discrimination. In addition, PCR amplification introduces errors during the library construction step, especially in regions near STRs such as homopolymer A or T runs. These types of errors are due to replication slippage events and result in high variability in the number of repeat elements (Fig. 5) . It then becomes very difficult to distinguish true events at these loci from stutter errors. Moreover, as described in Box 1, candidate mutations within STRs can have The validation rate, positive predictive value (PPV), is computed by the following: PPV = no. TP/(no. TP + no. FP), where no. TP is the number of true-positive calls and no. FP is the number of false-positive calls. Both WGS (mean coverage = ~70×) and WES (mean coverage = ~330×) were performed on Illumina Hiseq 2000 sequencers under 2× 100 bp mode (described in Fang et al . 18 ). The construction of WGS libraries here involved a procedure of PCR amplification. The exome capture kit used for WES was NimbleGen SeqCap EZ Exome v2.0, which was designed to pull down 36 Mb of the human genome. The sensitivity performance is assessed using the high-confidence call set shared by WGS and WES data (both Illumina HiSeq2000 platform) from eight samples using all available coverage (70× mean coverage). We down-sampled the reads to a fraction of the original coverage and performed indel calling again. Compared with the original set at 70× mean coverage, we report the percentage of variants that could still be called at a reduced coverage. The y axis represents the percentage of the high confidence indels revealed at a down-sampled data set. The x axis represents the mean coverage of the eight down-sampled genomes. Among the entire call set, ~61% of the indels are heterozygous and the remaining 39% are homozygous. Performance for heterozygous (blue) and homozygous (green) indel detection is shown by separate curves. Reduced coverage indeed affected the detection of heterozygous indels more than that of homozygous ones. an ambiguous signature. Therefore, for indel analysis, we recommend using PCR-free protocols, which can substantially reduce the number of errors around those loci. Moreover, as reported in this protocol, filtering based on the combination of alternative allele coverage (aac) and k-mer χ 2 score is an effective strategy for filtering out additional false positives without compromising much on sensitivity.
Population studies. Large-scale sequencing studies, involving hundreds or thousands of samples, are now becoming more and more widespread. Here we aim to introduce some of the advantages of having access to a collection of sequenced individuals. Even though Scalpel does not directly provide an application program interface for joint calling on more than four samples, we provide examples and a recommendation for how to take advantage of such information if available. The basic idea is to aggregate all the genetic variants detected in the samples into a database framework with associated genotypes and genomic annotation. There are existing flexible systems, such as GEMINI 40 , for exploring genetic variation for disease and population genetics. Analyzing the genetic code of a large cohort of individuals has the potential to shed light on the mechanisms underpinning complex diseases such as autism and schizophrenia. These studies are generally focused on the detection and analysis of rare variants that can explain the phenotype of the affected individuals. The population frequency of such rare mutations is usually so low that it is obscured by the noise in the sequencing data, making any real biological signal undetectable. In these circumstances, the population can be used to devise effective filtering strategies. For example, in a large-scale autism study in which Scalpel was used 7 , the population database was used to identify rare variants by filtering highly polymorphic loci with many more mutations than expected in the general population, as well as common variants using minor allele frequency cutoffs. Typically, variants for which the minor allele is present in >1% of a population are considered common. By removing these locations from the analysis, the biological signal started to emerge: an enrichment of frameshift de novo mutations in the affected child as compared with the unaffected sibling. The highly polymorphic regions were later found to enrich for homopolymers and other STRs, which are known to be more susceptible to sequencing errors. In the case of de novo studies, it is extremely unlikely that the same mutation is present as de novo in multiple individuals; in such a case, the population information can be used again to filter out such candidates as artifacts in the sequencing.
Cancer studies. Detection of somatic variation in tumornormal matched samples is complicated by different factors such as ploidy, clonality and purity of the input material. Moreover, the sensitivity and specificity of any somatic mutation calling approach varies along the genome because of differences in sequencing read depths, error rates, variant allele fractions (VAFs) of mutations and so on. Accounting for all these variables poses a very complex and challenging problem. However, the proper filtering parameters can eliminate the majority of Scalpel's false-positive calls. For example, Figure 6 show the effects of different Phred-scaled Fisher's exact score cutoffs used for filtering of a pair of highly concordant primary and metastatic samples from Branon et al. 41 . Figure 6 demonstrates that indels with a Indel quality was defined with respect to alternative allele coverage and χ 2 score, which is used in the PROCEDURE and described in Fang et al. 18 . 'Intersection' represents the shared indels from both the PCR-free and standard WGS indels. The number reported above a call set represent the total number of indels in that subset; the two data shared 2,684 variants, whereas 310 and 538 were specific to standard WGS and PCR-free data, respectively. Indel calls are further categorized (side-bars) based on their sequence composition: Poly A, Poly C, Poly G, Poly T, other-STR and non-STR. Note: although Poly C and Poly G indels exist in the call-set, their fractions are too minimal to be visualized in the plot. In fact, Poly A, Poly T and non-homopolymer STRs dominate the STR indels. Poly, homopolymer. Phred-scaled Fisher's exact score below 10 tend to have low variant allele fraction (VAF) values and are much more likely to be sequencing errors. In fact, the allele fraction of mutations exclusive to either the primary tumor or the metastasis is substantially lower with higher (more stringent) cutoffs. Similarly, the VAF distribution of the indels found only in the primary tumor shifts toward the expected distribution for these samples (with a peak at ~20%) as more conservative Fisher's exact test cutoffs are used. Not all errors are eliminated, however, especially in regions where very low support for a mutation in the normal sample or the tumor precludes the assembly of the reads. We are actively researching enhanced algorithms for such regions, including using a joint assembly within the same de Bruijn graph of the reads from both the tumor and the normal samples.
MaterIals
EQUIPMENT  crItIcal Make sure that the listed software tools are available within your UNIX PATH setting. For example, if you have your tools installed in a '/path/to/your/tools' directory, you can update your PATH setting to include this path by using the following command:
% export PATH=/path/to/your/tools:$PATH You can also add the command to your UNIX setting file ~/.bashrc.
Data  crItIcal This protocol and bioinformatics software is generally applicable and optimized for Illumina NGS data, including WGS and exome-captured sequencing data. We use the publicly available HiSeq WGS data from the Illumina Platinum Genomes 42 (http://www.ebi.ac.uk/ena/data/view/ERP001960) for the family of NA12878 as an illustration in this protocol. However, some specific parameters, such as the filtering criterion, may need to be adjusted accordingly for a different data set. EQUIPMENT SETUP Hardware setup The software used in this protocol is intended for operation on a 64-bit machine, running a 64-bit version of the Linux operating system. We recommend using a machine with at least 1.2 TB of disk storage available for whole-genome analysis and a minimum of 64 GB of RAM. The software will scale to the number of cores available; we recommend the use of at least ten cores, if possible, especially for whole-genome analysis. Software setup Download Scalpel's resource bundle containing the scripts for visualization and quality control of the indels (available as part of the Scalpel distribution). Download relevant files hosted on the Scalpel website, including the resource bundle:
% wget --no-check http://sourceforge.net/ projects/scalpel/files/scalpel-0.5.3.tar.gz; tar zxvf scalpel-0.5.3.tar.gz; cd scalpel-0.5.3; make; export PATH=../scalpel-0. • tIMInG Following this protocol, it will take ~48 h to complete the analysis of the exonic indels in the example WGS data on a machine with ten processing cores and at least 53 GB of RAM. However, the time could be variable depending on the user's actual computational power. Most of the run time is spent on read alignment. Notably, we can expect that, in the near future, there will be studies with larger sample sizes and deeper sequencing. Therefore, the run time may be longer, assuming the computer power remains the same. After filtering for acc, χ 2 scores and STR regions, the size of the high-quality inherited indels should follow a log-normal distribution (Fig. 7) . Similar observations of such a size distribution were also reported in the 1000 Genomes Project 47 and an analysis of 179 human genomes 13 . We also observed a much higher abundance of homopolymer A or T indels, relative to homopolymer C or G indels in the low-quality call set (Fig. 8) . Homopolymer A or T indels usually have low VAF, because homopolymer A or T molecules are enriched for PCR stutter/slippage artifacts. Conversely, the VAF of high-quality inherited indels follows an approximately normal distribution, with a mean of around The y axis represents the number of indels, whereas the x axis represents the size of indels in base pairs. We should expect a log-normal distribution of indels, with a majority of them being short-i.e., <5 bp in the human exonic regions 16 . This figure was generated using the data from Step 15. The y axis represents the number of indels, whereas the x axis represents the variant allele fraction (VAF). Homopolymer A or T indels should be more abundant than C or G indels in the call set, especially indels with very low VAF. Due to the limitations of PCR amplification, homopolymer A or T runs are more likely to result in inaccurate molecules 18 . This figure was generated using the data from Step 16. Low/ high-quality indels here were defined with respect to the coverage and χ 2 scores described in Steps 11 and 12. The VAF of high-quality inherited indels should follow an approximately normal distribution, with a mean of ~50%. In practice, because of sequencing and alignment biases, the mean of the normal distribution is usually slightly less than 50%. Low-quality indels usually have low VAF values, generally tending to be lower than 20%. This figure was generated using the data from Step 17.
One-pass search (15, 554) In-target indels or slightly <50% (Fig. 9) . This indicates that we observed equal read evidence for the two alleles in the genome.
expected number of indels that remains during the filtering cascade
As calling de novo indels requires a more sensitive analysis of the family members, we recommend using the '--two-pass' search option when discovering de novo events. Many more inherited indels will persist through the filtering cascade, as compared to the number of de novo events. This is because de novo events are extremely rare in comparison with inherited indels. De novo mutations are also particularly vulnerable to batch effects and random errors, as a correct analysis requires both high sensitivity and specificity in the entire family. In fact, among the in-target indels, ~51% of the inherited ones are of high quality, whereas only 5% of the de novo ones survived the filtering cascade (Fig. 10) .
Indel distribution within coding sequence
Because frameshift mutations can cause loss of function of a gene, these mutations are expected to be less frequent than frame-preserving mutations in the coding region. As shown in Figure 11 (produced at Step 23), indels whose size is a multiple of three are much more abundant than others with similar sizes (+1 or −1).
a list of novel inherited frameshift mutations in the family
Although this family has been investigated in many studies, many frameshift indels were not discovered in any public database, including 1000G, ExAC and ESP (table 4) . We observe a total of six novel frameshift mutations. Many of these indels are of a size larger than 5 bp. On the basis of Sanger validation of these loci, all 20 genotypes in four family members were successfully validated/confirmed (supplementary results; supplementary Methods). With the improvement of the indel-calling protocol introduced in this article, we are able to identify these previously undiscovered loss-of-function mutations. We also inspected the VCF file generated by the Illumina Platinum Genome project (release 8.0.1) for the presence of the six discovered frameshifts. Although the VCF file was generated using five different variant callers (Freebayes, Platypus, GATKv3, Cortex and Issac2), it contained only two of the six indels in table 4. This indeed further demonstrates the power of Scalpel over other methods, especially for detecting large indels.
the de novo indel in the child and the alignment IGV screenshot High-quality de novo indels usually share the following characteristics: (i) the number of reads in the region is close to the genome-wide mean coverage; (ii) there are balanced numbers of reads supporting both the reference and the alternative This figure was generated using data generated by Step 23, which was the set of inherited indels from the proband, NA12882. The y axis represents the number of indels, whereas the x axis shows the indel size. Stacked bar plots of insertions (red) and deletions (green) are shown in this figure. Indels with a size that is a multiple of three (frame-preserving) are more abundant than the frame-disrupting ones. allele; (iii) these indels are not located within or near STR regions; and (iv) in the parents' genome, there are no reads supporting the same indel presented in the child's genome. table 5 reports the de novo deletion found in the affected child. This is a 1-bp heterozygous frameshift deletion located in exon 4 of the gene HFM1. This HFM1 de novo deletion was also successfully validated in Sanger experiments (supplementary results; supplementary Methods). The genomic coordinate is chr1: 91859889, relative to the reference genome hg19. This variant has not been reported before in any of the widely used variant databases, such as 1000G, ESP6500, ExAC and CG46. Figure 12 shows the screenshot of the IGV alignment of all four genomes. We can see a distinct signature of the deletion presented only in the affected child, but not in anyone else in the family. 
